A detailed history of Pinnacle Bancorp, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 1,160 shares of NVO stock, worth $119,050. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,160
Previous 1,042 11.32%
Holding current value
$119,050
Previous $148,000 6.76%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$119.07 - $145.42 $14,050 - $17,159
118 Added 11.32%
1,160 $138,000
Q4 2023

Jan 25, 2024

BUY
$87.78 - $105.45 $43,890 - $52,725
500 Added 92.25%
1,042 $107,000
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $24,644 - $54,075
271 Added 100.0%
542 $49,000
Q3 2022

Oct 25, 2022

SELL
$95.28 - $116.93 $6,860 - $8,418
-72 Reduced 20.99%
271 $27,000
Q1 2022

Apr 14, 2022

SELL
$93.1 - $112.54 $1,489 - $1,800
-16 Reduced 4.46%
343 $38,000
Q3 2021

Oct 12, 2021

BUY
$84.42 - $106.62 $4,643 - $5,864
55 Added 18.09%
359 $34,000
Q1 2021

Apr 26, 2021

SELL
$67.06 - $75.82 $23,605 - $26,688
-352 Reduced 53.66%
304 $20,000
Q3 2020

Oct 13, 2020

BUY
$63.69 - $70.22 $7,579 - $8,356
119 Added 22.16%
656 $46,000
Q1 2020

Apr 09, 2020

SELL
$49.46 - $64.78 $19,784 - $25,912
-400 Reduced 42.69%
537 $32,000
Q4 2019

Jan 10, 2020

SELL
$49.86 - $58.26 $10,121 - $11,826
-203 Reduced 17.81%
937 $54,000
Q3 2019

Oct 08, 2019

BUY
$47.54 - $53.43 $9,650 - $10,846
203 Added 21.66%
1,140 $59,000
Q2 2019

Jul 08, 2019

BUY
$46.79 - $52.47 $5,755 - $6,453
123 Added 15.11%
937 $48,000
Q1 2019

Apr 05, 2019

SELL
$46.36 - $52.63 $2,318 - $2,631
-50 Reduced 5.79%
814 $43,000
Q4 2018

Mar 20, 2019

BUY
$41.54 - $47.25 $35,890 - $40,824
864 New
864 $40,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pinnacle Bancorp, Inc. Portfolio

Follow Pinnacle Bancorp, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.